SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating:
Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of fiduciary duties and other violations of law related to Eidos’ agreement to be acquired by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos’ shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-eidos-therapeutics-inc.American Renal Associates Holdings, Inc. (NYSE: ARA) regarding possible breaches of fiduciary duties and other violations of law related to American Renal Associates’ agreement to be acquired by affiliates of Nautic Partners, LLC. Under the terms of the agreement American Renal Associates’ shareholders will receive $11.50 per share in cash. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-american-renal-associates-holdings-inc.MVC Capital, Inc. (NYSE: MVC) regarding possible breaches of fiduciary duties and other violations of law related to MVC Capital’s agreement to be acquired by Barings BDC, Inc. Under the terms of the agreement MVC Capital’s shareholders will receive $0.39492 in cash and 0.94024 of a share of Barings BDC per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-mvc-capital-inc.Cancer Genetics, Inc. (NASDAQ CM: CGIX) regarding possible breaches of fiduciary duties and other violations of law related to Cancer Genetics’ agreement to merge with StemoniX, Inc. Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cancer-genetics-inc.You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising. Prior results do not guarantee a similar outcome.CONTACT:Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow